Protagonist Therapeutics, Inc Business Operations Contracts & Agreements
7 Contracts & Agreements
- Collaboration Agreements (7 contracts)
- License and Collaboration Agreement by and between Protagonist Therapeutics, Inc. and Takeda Pharmaceuticals USA, Inc. dated January 31, 2024 (Filed With SEC on May 7, 2024)
- Second Amendment to the Exclusive Janssen License and Collaboration Agreement, dated July 27, 2021, by and between Protagonist Therapeutics, Inc. and Janssen Biotech, Inc (Filed With SEC on November 3, 2021)
- First Amendment to Exclusive License and Collaboration Agreement, by and between Protagonist Therapeutics, Inc. and Janssen Biotech, Inc., dated May 7, 2019 (Filed With SEC on August 7, 2019)
- LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN JANSSEN BIOTECH, INC. AND PROTAGONIST THERAPEUTICS, INC. (Filed With SEC on July 31, 2017)
- Agreement onaddition of Additional Collaboration Program hereinafter (AACP) made effective as of September 16th 2013 (AACP Effective Date). (Filed With SEC on August 9, 2016)
- DATED 16 JUNE 2012 (1) ZEALAND PHARMA A/S (2) PROTAGONIST PTY. LTD. (3) PROTAGONIST THERAPEUTICS, INC. RESEARCHCOLLABORATION AND LICENSE AGREEMENT ZEALAND PHARMA/PROTAGONIST... (Filed With SEC on August 9, 2016)
- Agreement onaddition of Additional Collaboration Program hereinafter (AACP) made effective as of September 16th 2013 (AACP Effective Date). (Filed With SEC on July 11, 2016)
